Alkermes

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Diversity & Inclusion | Alkermes

Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

Dec 27, 2023 11:25 AM ET

Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive our innovation, and their passion and commitment to excellence are the cornerstone of our success.

Flexible Media Releases

Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

Dec 27, 2023 11:25 AM ET

Corporate Governance at Alkermes

Dec 20, 2023 12:00 PM ET

Alkermes’ Commitment to Integrity and Compliance

Dec 18, 2023 1:30 PM ET

Alkermes’ Culture of Employee Engagement and Wellness

Dec 14, 2023 10:40 AM ET

Patient Advocacy and Community Engagement at Alkermes

Dec 11, 2023 2:20 PM ET

Pharmaceuticals in the Environment

Nov 29, 2023 3:00 PM ET

Environmental Protection & Sustainability at Alkermes

Nov 21, 2023 11:30 AM ET

Alkermes Celebrates #Movember for Men’s Health Awareness Month

Nov 20, 2023 1:30 PM ET

Alkermes' Waste Optimization Highlights

Nov 16, 2023 10:10 AM ET

Our Commitment to Caregivers

Nov 14, 2023 1:25 PM ET

Product Stewardship and Environmental Impact at Alkermes

Nov 13, 2023 12:25 PM ET

Caring for Caregivers: Alkermes Celebrates National Caregivers Month

Nov 10, 2023 2:40 PM ET

Environmental Health and Safety at Alkermes

Nov 8, 2023 11:15 AM ET

Operating and Growing Responsibly at Alkermes

Oct 31, 2023 1:10 PM ET

Alkermes CEO Reflects on Living Company Purpose

Oct 23, 2023 1:50 PM ET

Campaigns

Alkermes: Diversity, Inclusion & Belonging

Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

Alkermes: Corporate Responsibility

We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

Alkermes Medicines & Focus: Serious Mental Illness

We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

Alkermes Medicines & Focus: Cancer

We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

Alkermes Inspiration Grants®

Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

Alkermes Medicines & Focus: Addiction

We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...

Videos

Health & Healthcare | Alkermes

Did You Know a Person's Biology and Environment Can Increase Their Predisposition to Addiction?

Sep 14, 2022 12:15 PM ET

Anyone can develop AUD, however, certain factors like biology and environment may contribute to a person's predisposition.